U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07223658) titled 'Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia' on Oct. 30.
Brief Summary: Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and effects on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) of single-dose ARO-DIMERPA and multiple doses of ARO-DIMERPA in adult participants with mixed hyperlipidemia.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Hyperlipidemia; Mixed
Intervention:
DRUG: ARO-DIMERPA
Subcutaneous (SC) injection
DRUG: Placebo
Calculated volume to match active treatment by SC injection
Recruitment Status: NOT_...